|

Cilta-cel Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: JNJ-68284528, LCAR-B38M CAR-T cells

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • Janssen Research & Development, LLC2

Indications

  • Multiple Myeloma2
  • Cancer2

Phoenix, Arizona1 trial

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Mayo Clinic Cancer Center-Scottsdale

Phase 4

Tampa, Florida1 trial

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.